BIO CEO & Investor Conference

February 8-9, 2021・New York Marriott Marquis

Errata

Corrections, Sponsor and Speaker Additions, and Individual Speaker Cancellations to the printed Program Guide: 2020 BIO CEO & Investor Conference

Programming Updates

Monday, February 10

Expanding the Toolkit for Fighting Solid Tumors

--(Monday, February 10, 9:00-9:55 am, Lyceum Complex, 5th Floor)

NEW: Daniel O’Connor, Chief Executive Officer, OncoSec Immunotherapies

 

Fireside Chat with Carol Lynch, President of Sandoz US and Head of North America, Sandoz, a Novartis division

--(Monday, February 10, 10:00-10:55 am, Lyceum Complex, 5th Floor)

NEW: Moderator: Rob Wright, Chief Editor, Life Science Leader

 

Commercialization Strategies for Communicating Evidence of a Therapy’s Value

--(Monday, February 10, 11:00-11:55 am, Lyceum Complex, 5th Floor)

NEW: Stacey D. Seltzer, Partner, Aisling Capital

 

NEW: MINI-LESSON: Applying Game Theory to Negotiations and Business Development

--(Monday, February 10, 1:00-1:25 pm, Lyceum Complex, 5th Floor)

At this excerpt of BIO's executive education workshop, some core elements of Game Theory will be explained, followed by the application of Game Theory to enhance your negotiations skills via a biopharma example. A full-day workshop on the topic will be offered June 7, before the 2020 BIO International Convention.
Speakers:

  • Harm-Jan Borgeld, CSAP, PhD, Head, Alliance Management, Merck KGaA
  • Stefanie Schubert, CA-AM, PhD, Professor of Economics, SRH University Heidelberg

 

Preparing for NASH and Other New Liver Treatments

--(Monday, February 10, 1:30-2:25 pm, Lyceum Complex, 5th Floor)

CANCELLED: Scott L. Friedman, MD, Dean for Therapeutic Discovery and Chief, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai

 

Advances in Gene Therapy: Facing Challenges and Adapting for the Future

--(Monday, February 10, 3:30-4:25 pm, Lyceum Complex, 5th Floor)

NEW

  • Abhi Gupta, Senior Director, Global Gene Therapy, Pfizer Inc.
  • Emily Minkow, Chief Business Officer, Prevail Therapeutics

CANCELLEDAsa Abeliovich, MD, PhD, CEO and Founder, Prevail Therapeutics
 

Tuesday, February 11

NEW: Navigating the New CFIUS Regulations for Investments with U.S. Partners

--(Tuesday, February 11, 8:30-8:55 am, Julliard Complex, 5th Floor)

New national security regulations in the United States are changing the landscape for cross-border investments in biotechnology. In January 2020, new regulations were published for foreign investors into U.S. companies who now need to file with the Committee on Foreign Investment in the United States (CFIUS) to approve covered transactions before entering licensing deals or other equity investments. This session will update market participants on the evolving national security review process and its impact on the biotechnology industry, as well as consider how additional rules may impact future business development and investment opportunities.

Moderator: Cameron Arterton, Vice President, Tax Policy, Emerging Companies, BIO

Panelist: Richard C. Sofield, Partner, Wiley Rein LLP

 

Exploring Innovation in Cardiovascular Disease Therapeutics

--(Tuesday, February 11, 9:00-9:55 am, Lyceum Complex, 5th Floor)

NEW:

  • Moderator: Alethia Young, Managing Director, Head of Healthcare & Senior Biotech Research Analyst at Cantor Fitzgerald
  • Ari Brettman MD, Managing Director, Blackstone Life Sciences

CANCELLED: Jonathan Freeman, PhD, Senior Advisor, Blackstone Life Sciences

 

Fireside Chat with Evan Loh, MD, Chief Executive Officer, Paratek Pharmaceuticals

--(Tuesday, February 11, 12:00-12:55 pm, Julliard Complex, 5th Floor)

NEW: Moderator: Phyllis Arthur, Vice President, Infectious Diseases & Diagnostics Policy, BIO

 

Industry Approaches for Hiring and Developing an Inclusive Workforce

--(Tuesday, February 11, 1:00-1:55 pm, Lyceum Complex, 5th Floor)

NEW:

  • Wanda Bryant Hope, Chief Diversity & Inclusion Officer, Johnson & Johnson
  • Ahtis Davis, Executive Director, Advancing Black Pathways, JPMorgan Chase

 

Market Outlook—Market Performance and IPO Class of 2020

--(Tuesday, February 11, 4:00-4:55 pm, Lyceum Complex, 5th Floor)

NEW: Mara Goldstein, Managing Director, Biotechnology Analyst, Mizuho Securities

CANCELLED: Jennifer Sheng, Managing Director, Healthcare Equity Capital Markets, Citigroup Global Markets

Logistics

Company Presentation Breakout Room (*NEW): When you want to continue the conversation with a Company Presentation speaker after their presentation, go with them to the Company Presentation Breakout Room, the O’Neill Room on the 4th Floor.

New Sponsors